GNANI, ALESSANDRA
 Distribuzione geografica
Continente #
EU - Europa 307
NA - Nord America 302
AS - Asia 55
AF - Africa 17
Totale 681
Nazione #
US - Stati Uniti d'America 299
GB - Regno Unito 95
SE - Svezia 66
IT - Italia 35
CN - Cina 29
DE - Germania 27
GR - Grecia 13
IE - Irlanda 13
IN - India 13
CH - Svizzera 11
FR - Francia 11
UA - Ucraina 11
BE - Belgio 6
ZA - Sudafrica 6
BG - Bulgaria 5
JO - Giordania 5
RU - Federazione Russa 5
TG - Togo 5
EE - Estonia 4
FI - Finlandia 4
CA - Canada 3
CI - Costa d'Avorio 3
IR - Iran 3
KR - Corea 2
NG - Nigeria 2
TR - Turchia 2
NL - Olanda 1
PH - Filippine 1
SC - Seychelles 1
Totale 681
Città #
Southend 85
Chandler 49
Fairfield 30
Woodbridge 21
Ann Arbor 18
Ashburn 18
Cambridge 16
Houston 16
Wilmington 16
Princeton 14
Dublin 13
Seattle 10
Bern 9
New York 8
Westminster 8
Bologna 7
Beijing 6
Brussels 6
Jacksonville 6
Padova 6
Turin 6
Amman 5
Lomé 5
Medford 5
Sofia 5
Hebei 4
Helsinki 4
Nanjing 4
Abidjan 3
Grafing 3
Milan 3
San Diego 3
Shenyang 3
Abeokuta 2
Athens 2
Bremen 2
Dearborn 2
Istanbul 2
Jinan 2
Kish 2
North York 2
Riolo Terme 2
Andover 1
Berlin 1
Boardman 1
Cesenatico 1
Changsha 1
Chicago 1
Falls Church 1
Frankfurt am Main 1
Groningen 1
Haikou 1
Hefei 1
Jiaxing 1
Kilburn 1
Lausanne 1
Leawood 1
Mahé 1
Manila 1
Mülheim 1
Ningbo 1
Norwalk 1
Orange 1
Paris 1
Redmond 1
Redwood City 1
Saint Petersburg 1
San Jose 1
Taizhou 1
Tianjin 1
Toronto 1
Viserba 1
Washington 1
Totale 464
Nome #
Efficacy and Clinical Outcome of Philadelphia (Ph) Positive Acute Lymphoblastic Leukemia (ALL) Patients Treated with Second Generation Tyrosine Kinase Inhibitors (TKIs): The Bologna Experience 205
Efficacy and clinical outcome of Philadelphia (Ph) positive acute lymphoblastic leukemia (ALL) patients treated with second generation tyrosine kinase inhibitors (TKIs): The Bologna experience 144
Contribution Of ABL Kinase Domain Mutations To Imatinib Resistance In Different Subsets Of Philadelphia-Positive Patients. By The GIMEMA Working Party On Chronic Myeloid Leukemia 121
Resistance to second-line tyrosine kinase inhibitor treatment in imatinib-resistant Philadelphia-positive leukemia patients can be anticipated by ultra-deep sequencing of the BCR-ABL kinase domain using Roche 454 technology 80
Expression of different isoforms of the B-cell mutator activation-induced cytidine deaminase (AID) in BCR-ABL1-Positive Acute Lymphoblastic Leukemia (ALL) Patients 76
New drugs to overcome meccanisms of resistance in Ph+ leukemia: Bosutinib 74
Totale 700
Categoria #
all - tutte 1.491
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.491


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201910 0 0 0 0 0 0 0 0 0 0 2 8
2019/2020189 21 5 1 16 23 29 25 19 24 8 10 8
2020/202170 21 6 0 2 2 3 0 11 10 5 3 7
2021/2022151 8 2 11 16 14 13 3 10 10 10 25 29
2022/2023172 18 35 7 23 9 14 5 7 30 0 13 11
2023/202442 0 9 3 5 4 15 3 0 2 1 0 0
Totale 700